Two landmark CMS rules took effect June 1, 2026, reshaping how practices interact with Medicare Advantage payers and their Medicaid patient populations simultaneously.
CMS’s finalized CY 2027 MA and Part D rule (published April 6, 2026) governs coverage beginning January 1, 2027, but its marketing, enrollment, and administrative provisions began taking effect June 1 and October 1, 2026. Key changes impacting practices:
On June 1, 2026, CMS simultaneously issued an interim final rule implementing a new statutory Medicaid work requirement. Non-pregnant adults ages 19–64 who are not entitled to or enrolled in Medicare must now demonstrate 80 hours per month of qualifying community engagement activities — employment, work program participation, community service, or enrollment in education at least half-time — or earn at least $580/month (80× the federal minimum wage) as a condition of Medicaid eligibility.
The June 1 dual rule issuance is the clearest signal yet that federal payer policy is tightening simultaneously on Medicare Advantage (administrative simplification) and Medicaid (eligibility restriction). Practices in the middle — billing both programs — should stress-test their payer mix assumptions for 2027 now, while there is still time to build patient engagement and coverage transition workflows before the mandates take effect.
Three prior authorization developments this week signal that PA reform is accelerating across payers, drugs, and network relationships — each with direct billing implications for physician practices.
On April 10, 2026, CMS issued a proposed rule extending federal interoperability and prior authorization requirements to cover drugs for the first time. The rule would require Medicare Advantage organizations, Medicaid managed care plans, CHIP agencies, and QHP issuers to:
If finalized, most provisions would take effect October 1, 2027. The comment deadline falls approximately June 13, 2026 (60 days from publication). For practices with heavy specialty drug utilization — oncology, rheumatology, neurology — this proposed rule signals future relief from the manual drug PA burden that currently consumes 16+ hours per week per practice in administrative time.
As of January 1, 2026, when a patient changes insurance companies mid-treatment, the new plan must honor existing prior authorizations for benefit-equivalent in-network services during a 90-day transition period. This provision directly protects practices from mid-course treatment disruptions and associated rebilling cycles. For practices managing chronic disease patients with frequent insurance transitions — particularly in behavioral health, oncology, and cardiology — this rule materially reduces administrative rework.
Starting June 1, 2026, all NewYork-Presbyterian hospitals and Medical Group practices became out-of-network for most UnitedHealthcare Medicare Advantage members after contract negotiations failed. Patients undergoing active treatment before June 1 are protected as in-network until August 29, 2026, after which non-emergency visits become out-of-network unless UHC approves continuation.
The dispute underscores a growing tension in Medicare Advantage contracting: as MA plans cut costs and administrative overhead, provider contract terms are tightening. A single out-of-network surprise bill generates an average 4.2 additional staff hours to resolve and risks patient complaints under the No Surprises Act framework.
| PA Reform Milestone | Status | Effective Date |
|---|---|---|
| Standard PA decisions within 7 days (medical) | ✓ Required | Jan 1, 2026 |
| Expedited decisions within 72 hours | ✓ Required | Jan 1, 2026 |
| 90-day PA continuity on insurance change | ✓ Required | Jan 1, 2026 |
| First-ever payer PA metric public reporting | ✓ Required | March 31, 2026 |
| ePA for drugs (CMS proposed rule) | ● Proposed | Oct 1, 2027 if finalized |
| 80% electronic real-time PA approvals (industry pledge) | ● Committed | 2027 |
If you participate in Medicare Advantage networks and serve patients who may have sought care at NewYork-Presbyterian or a similarly disrupted health system in your market, alert your front desk now — patients may not know their coverage status has changed. Verify MA network participation at every encounter for patients with UHC MA coverage near disputed hospital systems.
In the biggest ambulatory RCM technology announcement of the year, athenahealth unveiled on June 3, 2026 a roadmap of more than 80 AI-native features built into its athenaOne platform — all designed to eliminate manual administrative work across the ambulatory revenue cycle. The announcement, timed ahead of the HFMA Annual Conference, represents the clearest signal yet that AI-native RCM has moved from experimentation to embedded infrastructure for independent and small-group practices.
The 80+ features target the highest-friction points in the revenue cycle — patient insurance errors, coding inaccuracies, prior authorization delays, and claim denials. Key capabilities already live or releasing soon:
The athenahealth announcement lands in a market where 63% of providers have introduced AI in some capacity to their workflows but only 15% have fully integrated AI into standard RCM operations. Black Book Research found that 74% of qualified respondents now prioritize denial prevention over post-denial recovery — a fundamental operating model shift enabled only by AI-powered pre-submission intelligence.
The athenahealth roadmap is not just a product announcement — it is a benchmark. If your practice’s current billing platform cannot demonstrate 15%+ reductions in insurance-related denials or 25%+ improvements in coding denial recovery, you now have a public comparison point to take into your vendor conversation. Express Coding’s broad availability in July 2026 creates a specific ask: request a demo before Q3 billing cycles begin.
This week brings four distinct coding developments with immediate billing impact. The most urgent: a critical code transition that generates automatic claim denials if old codes remain active in your billing system.
Practices billing Collaborative Care Management (CoCM) services face an immediate compliance risk: the legacy CPT codes 99492, 99493, and 99494 are being replaced by new G-codes — G0568 and G0570 (with a companion code) — and practices that continue billing the old CPT codes will receive claim denials. This transition affects:
The billing code structure itself is preserved — the time thresholds and documentation requirements carry forward — but the billing codes must be updated in every EHR template, billing system, and clearinghouse mapping immediately.
CMS released the 2026 National Correct Coding Initiative (NCCI) policy manual with material changes in two high-risk specialties:
CPT 2026 expanded the billable code set for AI-assisted diagnostics in radiology, pathology, and cardiology. Practices using AI tools for diagnostic support must confirm their AI tools map to specific CPT codes and that documentation supports medical necessity for the AI-assisted interpretation — not merely the underlying test. Separately, updated guidance for 2026 clarifies split/shared E/M documentation when a visit is shared between a physician and NPP, with payer-specific narrowing of acceptable documentation from UHC, Aetna, and Cigna.
The CoCM code transition is not optional — denials begin immediately on old CPT codes 99492–99494. Pull a report of all CoCM claims billed in the past 30 days and verify the code set in your system. A denial rate spike on behavioral health claims is the most visible symptom of this code gap, and retroactive corrections require both resubmission and patient record reconciliation.
The mid-year RCM data is in, and it is not flattering. Denial rates are approaching 20% in many practice environments — double the historic industry norm of 10%. More alarming: 60% of denials still go unappealed, a number that has barely moved despite years of industry warnings. The math is unsparing: a $300 average denial left unappealed at a 60% non-appeal rate means $180 per denial walking out the door permanently.
| KPI | Industry Average | MGMA Top Quartile | Warning Threshold |
|---|---|---|---|
| Days in Accounts Receivable | 38–42 days | 28–32 days | >45 days |
| Clean Claim Rate | 91–94% | 97–99% | <90% |
| Denial Rate | 10–20% | <5% | >15% |
| Denial Appeal Rate | 35–40% | >75% | <25% |
| Patient Collection Rate | 60–72% | >80% | <55% |
| A/R >90 Days as % of Total | 18–22% | <12% | >25% |
Every percentage point of clean claim rate improvement removes approximately 0.5–1 day from Days in AR, because rework adds 30–60 days to the average touched claim’s collection cycle. A practice moving from 92% to 97% clean claim rate recovers 2.5–5 days from AR — equivalent to 6–12% faster cash velocity. For a $5M annual revenue practice, each recovered day in AR represents approximately $13,700 in accelerated collections.
Run a 90-day denial trend report segmented by denial reason code and payer. If CO-4 (inconsistent modifier), CO-96 (non-covered charge), or CO-97 (bundled procedure) codes are trending up, you have an NCCI compliance gap that the 2026 NCCI edits will expose further before Q3 ends. Set a threshold: any denial reason code representing more than 3% of total denials requires a root-cause audit this week.
Released this week ahead of the 2026 HFMA Annual Conference, Black Book Research’s provider-user RCM trends survey signals a decisive inflection point: hospitals and health systems are moving revenue cycle management from billing operations into enterprise financial-control infrastructure.
The next generation of hospital RCM will be defined by six capabilities, according to Black Book’s 2026 findings:
AI adoption is triggering a measurable reversal of RCM outsourcing decisions. Providers who outsourced billing operations are repatriating those functions using AI-powered platforms, citing greater control, faster response to payer policy changes, and lower per-claim costs versus external vendor contracts. This shift accelerates as platforms like athenahealth’s Express Coding, Innovaccer’s autonomous RCM, and others demonstrate quantifiable denial reduction and coding accuracy gains.
The HFMA Annual Conference is the industry’s defining benchmark event. Black Book’s live rankings for top-rated ambulatory RCM vendors will be released at the conference this year. Key sessions to track: autonomous coding ROI case studies, AI governance frameworks for billing compliance, and payer contract negotiation strategies in the denial-prevention era. Independent practices should attend or follow conference coverage closely for direct competitive intelligence on where health system RCM is heading.
Three overlapping compliance timelines converge this month. Revenue cycle and compliance teams should build these into their June–July work plans now.
CMS began enforcing the updated hospital price transparency requirements on April 1, 2026, following a 90-day grace period from the January 1 effective date. All hospital machine-readable files (MRFs) must now include:
Hospitals that violate price transparency requirements can reduce their civil monetary penalty by 35% by waiving the right to an administrative law judge hearing. CMS is cross-referencing MRF data, payer allowed-amount reports, and claim-level billing data to identify systematic discrepancies.
For Independent Practices: While hospital-level MRF requirements do not directly apply to physician practices, patient-facing good faith estimate obligations under the No Surprises Act remain fully in effect. Any practice billing facility fees through a hospital outpatient department or ASC arrangement must confirm the facility’s MRF compliance — because payer auditors increasingly cross-reference billing against MRF data.
The CMS-2454-IFC interim final rule published June 3, 2026, is open for public comment until July 31, 2026. Practices with significant Medicaid patient populations should consider submitting comments. Key comment angles:
The proposed rule expanding ePA to drug authorizations (Federal Register April 14, 2026) carries a standard 60-day comment period, placing the comment deadline at approximately June 13, 2026. Practices with heavy specialty drug portfolios should coordinate with billing vendors on comments supporting the 2027 implementation timeline.
If your practice bills under a hospital outpatient department or ASC arrangement, confirm the facility’s machine-readable file was updated by April 1, 2026, with median allowed amounts, 10th/90th percentile data, and Type 2 NPIs. Missing or incorrect MRF data is an increasingly common trigger for CMS compliance inquiries — and a mismatch between MRF rates and claim-level billing generates both compliance exposure and payer contract renegotiation pressure.
For independent practices, this week’s regulatory double-header — the Medicaid community engagement rule and the CY 2027 MA final rule — represents the most consequential simultaneous payer policy shifts since the 2020 E/M overhaul. The revenue cycle implications require immediate modeling, not a quarterly review.
For independent practices in primary care, behavioral health, and safety-net medicine, the Medicaid community engagement IFR is this week’s most operationally consequential development. Revenue cycle teams should model three scenarios for January 2027:
Field commentary confirms denial volumes are running 18–22% above recent baselines — driven by NCCI edit updates, tightening payer medical necessity criteria, and new documentation requirements. For independent practices without dedicated denial management staff, this volume increase hits harder: the average independent practice re-submits or appeals only 35–40% of its denied claims, versus 70–80% at larger health systems. The revenue differential compounds over time.
While 63% of providers have introduced AI in some capacity, only 15% have fully integrated AI into standard RCM operations. The adoption barriers — data privacy concerns (50%), trust in AI results (41%), and cost (31%) — are solvable, but the window is narrowing. Health systems scaling AI faster are gaining clean claim rate advantages that compound into payer contract leverage.
| Metric | Industry Average | Top-Quartile Independent | Your Q4 2026 Target |
|---|---|---|---|
| Days in AR | 38–42 days | <32 days | <35 days |
| Clean Claim Rate | 91–94% | >97% | >95% |
| Denial Rate | 10–20% | <5% | <8% |
| Denial Appeal Rate | 35–40% | >75% | >60% |
| Patient Collection Rate | 60–72% | >80% | >75% |
| AI in Billing Workflow | 63% partial | Fully integrated | At least 1 AI tool live |
Healthcare services EV/EBITDA multiples have moderated to approximately 11.5× (down from 14.5× in 2024) — meaning physician group valuations are softer, but independent practice viability has improved for groups with strong RCM discipline. DOJ and FTC consolidation scrutiny remains elevated. More physicians are choosing independence as payment reform creates new value-based care entry points for small groups — but only those with tight revenue cycles can sustain the financial runway independence requires.
The practices that will thrive through 2026 and into 2027 treat the revenue cycle as a strategic asset. This week’s regulatory double-header — MA rule changes and Medicaid work requirements — will separate practices that modeled their payer mix scenarios from those surprised by coverage disruption in Q1 2027. Start modeling now; it costs nothing and the downside of not modeling is material.
| Specialty | Key Update This Week | Billing Impact |
|---|---|---|
| Primary Care | CoCM codes 99492–99494 retire; must use G0568–G0570 now | Claims deny on old codes immediately — update templates now |
| Cardiology | UHC–NYP MA network collapse June 1; echocardiogram PA phase-out continues | Verify MA network status at every encounter; capture freed PA time |
| Orthopedics | −2.5% CY 2026 efficiency adjustment on surgical procedures | $125K annual reduction per $5M in Medicare surgical revenue |
| Oncology | CMS drug PA proposed rule comment deadline ~June 13 | Comment to support 2027 drug ePA relief; existing rules unchanged |
| Mental Health | CoCM code transition; telehealth geographic restrictions eliminated; psychotherapy rates updated | Update templates immediately; telehealth expansion creates new revenue opportunity |
| Radiology | ACR 2026 CPT coding updates released; UHC full interpretation report requirement active | Download ACR 2026 coding resources; ensure full report documentation for UHC |
| Neurology | 2026 NCCI updates affect EEG, EMG, nerve conduction, neurophysiologic monitoring | Audit modifier 26/TC usage and bundling pairs immediately |
| Gastroenterology | 2026 NCCI bundling rule clarifications for colonoscopy, EGD, ERCP combinations | Audit multi-procedure session claims for new edit pairs before Q3 |
The CoCM code transition is the most operationally urgent item this week for primary care. Practices running behavioral health integration programs must update billing templates immediately — the old CPT codes (99492, 99493, 99494) generate automatic denials. Simultaneously, the Medicaid community engagement rule creates new patient navigation complexity: primary care panels typically contain the highest concentration of affected Medicaid enrollees among non-pregnant working-age adults.
The UHC–NewYork-Presbyterian network collapse is a cautionary tale with direct cardiology implications. Echocardiograms and cardiac catheterization procedures were among the first services flagged for UHC PA phase-out — but simultaneous network disruptions mean patients may be inadvertently seen out-of-network. The CY 2027 MA Star Ratings rule removing 11 administrative process measures reduces plan administrative friction for cardiology documentation, but clinical documentation requirements for cardiac procedures are unchanged.
The −2.5% CY 2026 physician fee schedule efficiency adjustment hits surgical specialties hardest. For a group with $5 million in Medicare-allowable surgical charges, this translates to approximately $125,000 in reduced annual reimbursement. Specialty-specific RCM — accurate implant documentation, fracture care global period billing, and modifier-59 usage — becomes more financially material at this level of reimbursement pressure. Every undercoded procedure amplifies the baseline cut.
The drug PA proposed rule (comment deadline approximately June 13) is the most relevant regulatory development for oncology this week. Oncology practices managing chemotherapy administration codes face the highest per-PA administrative burden in medicine; ePA for drugs — if finalized for October 2027 — would represent material relief. Complex bundled claim rules for chemotherapy administration (CPT 96400 series) remain unchanged. Comment to strengthen the rule’s final implementation timeline.
Two significant changes intersect this week. First, the CoCM code transition affects any mental health integration program — old codes deny immediately. Second, the telehealth geographic and originating-site restrictions for Medicare-covered mental health services have been permanently eliminated, expanding billable telehealth access for Medicare patients receiving psychotherapy (90832, 90834, 90837; 2026 Medicare rates: $79.81–$158 per session) and psychiatric evaluations. Practices not yet billing telehealth for Medicare mental health patients are leaving revenue on the table.
Radiology: ACR 2026 CPT coding resources are now available with full descriptors for new, revised, and deleted codes. UHC’s requirement for complete radiology interpretation reports (not just impressions) remains active — any radiology practice submitting claims to UHC without full interpretation documentation risks denials on AI-flagged claim review. Neurology: The 2026 NCCI updates for neurophysiologic monitoring, EEG, and EMG require an immediate modifier 26/TC audit — incorrect modifier usage is the leading source of CO-4 denials in neurology. Gastroenterology: The clarified bundling rules for colonoscopy, EGD, and ERCP procedural families create new edit pairs at payer adjudication — practices billing multiple GI procedures per session should run a prospective audit against the 2026 NCCI tables before the next billing cycle.
Seven specific actions for the week of June 5, 2026, directly tied to this issue’s content: